Lexicon Pharmaceuticals Inc (LXRX) stock saw a decline, ending the day at $0.69 which represents a decrease of $-0.02 or -2.82% from the prior close of $0.71. The stock opened at $0.72 and touched a ...
Explore the future of energy-efficient chips with CEO Brandon Lucia. Discover how efficiency is reshaping technology and ...
H.C. Wainwright has recently initiated Lexicon Pharmaceuticals Inc (LXRX) stock to Buy rating, as announced on June 17, 2024, according to Finviz. Earlier, on April 30, 2024, Leerink Partners had ...